Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?

Medical Hypotheses

Volumn 70, Issue 6, 2008, Pages 1174-1178

  Ajonuma, Louis Chukwuemeka ^a  

^a St Mary's Maternity Hospital   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL SODIUM CHANNEL; ESTROGEN; GONADOTROPIN DERIVATIVE; HEPARIN; ION CHANNEL; MUTANT PROTEIN; PROGESTERONE; STEROID; TRANSMEMBRANE CONDUCTANCE REGULATOR; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAPILLARY PERMEABILITY; CHROMOSOME 6P; CLINICAL FEATURE; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG HALF LIFE; DRUG MECHANISM; EPITHELIUM CELL; FERTILIZATION IN VITRO; FLUID TRANSPORT; HUMAN; ION TRANSPORT; NONHUMAN; OVARY HYPERSTIMULATION; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RISK FACTOR; TREATMENT OUTCOME; UPREGULATION;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HUMANS; MODELS, BIOLOGICAL; OVARIAN HYPERSTIMULATION SYNDROME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42749092765     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.11.004     Document Type: Article

References (26)

1. Aboulghar M. Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod 18 (2003) 1140-1141
2. Ajonuma L.C., Lai l.T., Gui H.Z., Connie H.Y.W., Miu C.L., Lok S.H., et al. Estrogen - induced abnormally high cystic fibrosis transmembrane conductance regulator expression results in ovarian hyperstimulation syndrome Mol. Endocrinol 19 (2005) 3038-3044
3. Chan L.N., Tsang L.L., Rowlands D.K., Rochelle L.G., Boucher R.C., et al. Distribution of epithelial sodium channels (ENaC) subunits and cystic fibrosis transmembrane conductance regulator (CFTR) in murine reproductive tract. J Membr Biol 185 (2002) 165-176
4. Crooke A.C. Induction of ovulation with gonadotropins Br. Med Bull 26 (1970) 17-21
5. Costabile L., Unfer V., Manna C., Gerli S., Rossetti D., and Di Renzo G.C. Use of intramuscular progesterone versus intravenous albumin for the prevention of ovarian hyperstimulation syndrome. Gynecol Obstet Invest 50 (2000) 182-185
6. Delvigne A., and Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8 (2002) 559-577
7. Enskog A., Nilsson L., and Brannstrom M. Plasma levels of free vascular endothelial growth factor 165 (VEGF165) are not elevated during gonadotrophin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controls. Eur J Obstet Gynecol Reprod Biol 96 (2001) 196-201
8. Gabriel S.E., Brigman K.N., Koller B.H., Boucher R.C., and Stutts M.J. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266 (1994) 107-109
9. Geva E., et al. Follicular fluid levels of vascular endothelial growth factor are they predictive markers for ovarian hyperstimulation syndrome. J Reprod Med 44 (1999) 91-96
10. Haning Jr. R.V., Austin C.W., Carlson I.H., Kuzma D.L., Shapiro S.S., and Zweibel W.J. Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril 40 (1983) 31-36
11. Hyder S.M., Murthy L., and Stancel G.M. Progestin regulation of vascular hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8 (1996)
12. Krasnow J.S., Berga S.L., Guzick D.S., Zeleznik A., and Yeo K.T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 65 (1996) 552-555
13. Manau D., Balasch J., Arroyo V., Jimenez W., Fabregues F., Casamitjan Creus M., et al. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. J Clin Endocrinol Metab 83 (1998) 1489-1493
14. + conductance in human endometrial epithelium. J Physiol 513 (1998) 443-452
15. McElhinney B., Ardill J., Caldwell C., Lloyd F., and McClure N. Variations in serum vascular endothelial growth factor binding profiles and the development of ovarian hyperstimulation syndrome. Fertil Steril 78 (2002) 2
16. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 (1999) 9-225
17. Penzias A.S. Luteal phase support. Fertil Steril 77 (2002) 318-323
18. Raziel A., Friedler S., Schachter M., Strassburger D., Mordechai E., and Ron-El R. Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome. Hum Reprod 17 (2002) 107-110
19. Schenker J.G., and Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 30 (1978) 255-268
20. Schwarzler P., Abendstein B.J., Klingler A., Kreuzer E., and Rjosk H.K. Prevention of severe ovarian hyperstimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression - a prospective randomized study. Human Fertil 6 (2003) 125-129
21. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., et al. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
22. Shifren J., Tseng J., Zaloudek C., Ryan I., Meng Y., Ferrara N., et al. Ovarian steriod regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81 (1996) 3112-3118
23. Tischer E., Mitchell R., Silva M., Gospodawicz D., Fiddes J.C., and Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 (1991) 11947-11954
24. Torry D., Holt V., Harris G., Caudle M., and Torry R. Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril 66 (1996) 72-80
25. Watkins R.H., D'Angio C.T., Ryan R.M., Patel A., and Maniscalco W.M. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury. Am J Physiol 276 (1999) 858-867
26. Wei M.H., Popescu N.C., Lerman M.I., Merrill M.J., and Zimonjic D.B. Localization of the human vascular endothelial cell growth factor gene, VEGF, at chromosome 6p12. Hum Genet 97 (1996) 794-797